Richard S Swain (Richard Swain)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 6

Top Venues

Pharmacoepidemiology and drug safety

Leukemia

Diabetes care

Drug safety

US Food and Drug Administration

Johns Hopkins University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

US Food and Drug Administration

United States

Epidemiologist :: Center for Drug Evaluation and Research

Oak Ridge Institute for Science and Education Oct 01 2015

United States

Epidemiology Post-Doctoral Fellow :: Food and Drug Administration, Center for Drug Evaluation and Research

Evidera Jun 01 2011 - Oct 01 2015

United States

Research Associate

George Washington University Jan 01 2009 - Dec 31 2011

United States

Instructional Assistant

George Washington University Feb 01 2010 - Aug 31 2010

United States

Data Analyst

GW Cancer Institute Patient Navigation Research Program Jun 01 2009 - Aug 31 2010

United States

Assistant to the Data Manager

Education History

Johns Hopkins University

United States

PHD :: Epidemiology

Kansas State University

United States

BSC :: Biology, Microbiology

Publications

Dinci Pennap, Richard S Swain, Sandia Akhtar, Jiemin Liao, Yuqin Wei, Jiaqi Li, Michael Wernecke, Thomas E MaCurdy, Jeffrey A Kelman, Andrew D Mosholder, David J Graham
Comparing the Centers for Medicare and Medicaid Services (CMS) enrollment data death dates to the National Death Index (NDI). Pharmacoepidemiology and drug safety 33 (3) (2024)
Sonal Singh, Hassan Fouayzi, Kathryn Anzuoni, Leah Goldman, Jea Young Min, Marie Griffin, Carlos G Grijalva, James A Morrow, Christine C Whitmore, Charles E Leonard, Mano Selvan, Vinit Nair, Yunping Zhou, Sengwee Toh, Andrew Petrone, James Williams, Elnara Fazio-Eynullayeva, Richard S Swain, D Tyler Coyle, Susan Andrade
Diagnostic Algorithms for Cardiovascular Death in Administrative Claims Databases: A Systematic Review. Drug safety 42 (4) (2020)
Kelly J Norsworthy, Armen Avagyan, Steven T Bird, Yuchen Li, Sandia Akhtar, Jiemin Liao, Michael Wernecke, Albert B Deisseroth, Meredith Chuk, Thomas E MaCurdy, Richard S Swain, Jeffrey A Kelman, Ann T Farrell, R Angelo de Claro, Richard Pazdur, Gideon Blumenthal, David J Graham
Second cancers in adults with acute promyelocytic leukemia treated with or without arsenic trioxide: a SEER-medicare analysis. Leukemia 34 (11) (2020)
Christian Hampp, Richard S Swain, Casie E Horgan, Elizabeth Dee, Yandong Qiang, Sarah K Dutcher, Andrew Petrone, Rong Chen Tilney, Judith C Maro, Catherine A Panozzo
Use of Sodium-Glucose Cotransporter 2 Inhibitors in Patients With Type 1 Diabetes and Rates of Diabetic Ketoacidosis. Diabetes care 43 (1) (2019)
Dana Y Teltsch, Soulmaz Fazeli Farsani, Richard S Swain, Stefan Kaspers, Samuel Huse, Christina Cristaldi, Beth L Nordstrom, Kimberly G Brodovicz
Development and validation of algorithms to identify newly diagnosed type 1 and type 2 diabetes in pediatric population using electronic medical records and claims data. Pharmacoepidemiology and drug safety 28 (2) (2019)
Richard S Swain, Lockwood G Taylor, Tiffany S Woodworth, Candace C Fuller, Andrew B Petrone, Talia J Menzin, Nicole R Haug, Sengwee Toh, Andrew D Mosholder
Overall and cause-specific mortality in the Sentinel system: A power analysis. Pharmacoepidemiology and drug safety 27 (12) (2018)

Richard S Swain.css-eqlu8i{font-size:small;padding-left:4px;} (Richard Swain)

Publication Activity (10 Years)

Top Topics

Top Venues

Richard S Swain (Richard Swain)